Oxford and London, UK, 05 March 2025: OBN (UK) Ltd., the membership organisation whose mission is to catalyse success in the ...

Mikael Dolsten, M.D., Ph.D., to its Board of Directors. Dolsten, who served as Pfizer’s chief scientific officer and ...

Of course, Pharma companies cannot simply trust any new ... to conduct this type of preclinical testing. Translating R&D use to real-world patient applications Physicians look to the research ...